Perfluorooctanoic acid and perfluorononanoic acid in fetal and neonatal mice following in utero exposure to 8-2 fluorotelomer alcohol

Toxicological Sciences

Volumn 95, Issue 2, 2007, Pages 452-461

  Henderson, W Matthew ^a,b,c   Smith, Mary Alice ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Fetal and neonatal distribution; Fluorotelomer alcohols (FTOH); PFNA; PFOA

Indexed keywords

8 2 FLUOROTELOMER ALCOHOL; ALCOHOL; PERFLUORO COMPOUND; PERFLUORONONANOIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS DEVELOPMENT; GAS CHROMATOGRAPHY; LACTATION; LIVER LEVEL; MASS SPECTROMETRY; MATERNAL BLOOD; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRENATAL EXPOSURE; TERATOGENICITY;

ANIMALS; ANIMALS, NEWBORN; BODY BURDEN; BODY WEIGHT; ENVIRONMENTAL POLLUTANTS; FATTY ALCOHOLS; FEMALE; FLUOROCARBONS; GESTATIONAL AGE; LIVER; MICE; MICE, INBRED STRAINS; OCTANOIC ACIDS; ORGAN SIZE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TISSUE DISTRIBUTION;

MUS;

EID: 33846502288     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl162     Document Type: Article

References (59)

1. Andersen, M. E., Clewell, H. J., 3rd, Tan, Y. M., Butenhoff, J. L., and Olsen, G. W. (2006). Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeysΡobing the determinants of long plasma half-lives. Toxicology 227, 156-164.
2. Bahn, A., Ebbinghaus, C., Ebbinghaus, D., Ponimaskin, E. G., Fuzesi, L., Burckhardt, G., and Hagos, Y. (2004). Expression studies and functional characterization of renal human organic anion transporter 1 isoforms. Drug Metab. Dispos. 32, 424-430.
3. Buist, S. C., Cherrington, N. J., Choudhuri, S., Hartley, D. P., and Klaassen, C. D. (2002). Gender-specific and developmental influences on the expression of rat organic anion transporters. J. Pharmacol. Exp. Ther. 301, 145-151.
4. Buist, S. C., and Klaassen, C. D. (2004). Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab. Dispos. 32, 620-625.
5. Butenhoff, J., Costa, G., Elcombe, C., Farrar, D., Hansen, K., Iwai, H., Jung, R., Kennedy, G., Jr, Lieder, P., Olsen, G., et al. (2002). Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol. Sci. 69, 244-257.
6. Butenhoff, J. L., Kennedy, G. L., Jr, Frame, S. R., O'Connor, J. C., and York, R. G. (2004a). The reproductive toxicology of ammoniumperfluorooctanoate (APFO) in the rat. Toxicology 196, 95-116.
7. Butenhoff, J. L., Kennedy, G. L., Jr, Hinderliter, P. M., Lieder, P. H., Jung, R., Hansen, K. J., Gorman, G. S., Noker, P. E., and Thomford, P. J. (2004b). Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. Toxicol. Sci. 82, 394-406.
8. Calafat, A. M., Kuklenyik, Z., Caudill, S. P., Reidy, J. A., and Needham, L. L. (2006). Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ. Sci. Technol. 40, 2128-2134.
9. Dinglasan, M. J., Ye, Y., Edwards, E. A., and Mabury, S. A. (2004). Fluorotelomer alcohol biodegradation yields poly- and perfluorinated acids. Environ. Sci. Technol. 38, 2857-2864.
10. Dinglasan-Panlilio, M. J., and Mabury, S. A. (2006). Significant residual fluorinated alcohols present in various fluorinated materials. Environ. Sci. Technol. 40, 1447-1453.
11. Ehresman, D. J., Froehlich, J. W., Olsen, G. W., Chang, S. C., and Butenhoff, J. L. (2006). Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. (Environ. Res. available online 21 June 2006, doi:10.1016/j.envres.2006.06.008.)
12. Ellis, D. A., Martin, J. W., De Silva, A. O., Mabury, S. A., Hurley, M. D., Sulbaek Andersen, M. P., and Wallington, T. J. (2004). Degradation of fluorotelomer alcohols: A likely atmospheric source of perfluorinated carboxylic acids. Environ. Sci. Technol. 38, 3316-3321.
13. Emmett, E. A., Shofer, F. S., Zhang, H., Freeman, D., Desai, C., and Shaw, L. M. (2006). Community exposure to perfluorooctanoate: Relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 48, 759-770.
14. Fasano, W. J., Carpenter, S. C., Gannon, S. A., Snow, T. A., Stadler, J. C., Kennedy, G. L., Buck, R. C., Korzeniowski, S. H., Hinderliter, P. M., and Kemper, R. A. (2006). Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat. Toxicol. Sci. 91, 341-355.
15. Grasty, R. C., Bjork, J. A., Wallace, K. B., Wolf, D. C., Lau, C. S., and Rogers, J. M. (2005). Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res. B Dev. Reprod. Toxicol. 74, 405-416.
16. Hansen, K. J., Clemen, L. A., Ellefson, M. E., and Johnson, H. O. (2001). Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35, 766-770.
17. Harada, K., Inoue, K., Morikawa, A., Yoshinaga, T., Saito, N., and Koizumi, A. (2005). Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ. Res. 99, 253-261.
18. Harris, M. W., and Birnbaum, L. S. (1989). Developmental toxicity of perfluorodecanoic acid in C57BL/6N mice. Fundam. Appl. Toxicol. 12, 442-448.
19. Henderson, W. M., Weber, E. J., Duirk, S. E., Washington, J. W., and Smith, M. A. (2006). Quantification of fluorotelomer-based chemicals in mammalian matrices by monitoring perfluoroalkyl chain fragments with GC/ MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., Available online 26 September 2006, 10.1016/j.jchromb.2006.08.042.
20. Hinderliter, P. M., Han, X., Kennedy, G. L., and Butenhoff, J. L. (2006). Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO). Toxicology 225, 195-203.
21. Hinderliter, P. M., Mylchreest, E., Gannon, S. A., Butenhoff, J. L., and Kennedy, G. L., Jr. (2005). Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats. Toxicology 211, 139-148.
22. Johansson, N., Fredriksson, A., and Eriksson, P. (2006). Neonatal exposure to perfluorooctane sulfonates (PFOS) and perfluorooctanoic acid (PFOA) cause deranged behaviour and increased susceptibility of the cholinergic system in adult mice. Toxicologist 90, 298. (Abstract).
23. Kennedy, G. L., Jr, Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., and Farrar, D. G. (2004). The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34, 351-384.
24. Kudo, N., Iwase, Y., Okayachi, H., Yamakawa, Y., and Kawashima, Y. (2005). Induction of hepatic peroxisome proliferation by 8-2 telomer alcohol feeding in mice: Formation of perfluorooctanoic acid in the liver. Toxicol. Sci. 86, 231-238.
25. Kudo, N., Katakura, M., Sato, Y., and Kawashima, Y. (2002). Sex hormoneregulated renal transport of perfluorooctanoic acid. Chem. Biol. Interact. 139, 301-316.
26. Kudo, N., and Kawashima, Y. (2003). Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J. Toxicol. Sci. 28, 49-57.
27. Kudo, N., Suzuki, E., Katakura, M., Ohmori, K., Noshiro, R., and Kawashima,Y. (2001). Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats. Chem. Biol. Interact. 134, 203-216.
28. Lau, C., Butenhoff, J. L., and Rogers, J. M. (2004). The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 198, 231-241.
29. Lau, C., Thibodeaux, J. R., Hanson, R. G., Narotsky, M. G., Rogers, J. M., Lindstrom, A. B., and Strynar,M. J. (2006). Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol. Sci. 90, 510-518.
30. Lau, C., Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Stanton, M. E., Butenhoff, J. L., and Stevenson, L. A. (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol. Sci. 74, 382-392.
31. Luebker, D. J., Case, M. T., York, R. G., Moore, J. A., Hansen, K. J., and Butenhoff, J. L. (2005a). Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215, 126-148.
32. Luebker, D. J., York, R. G., Hansen, K. J., Moore, J. A., and Butenhoff, J. L. (2005b). Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: Dose-response, and biochemical and pharamacokinetic parameters. Toxicology 215, 149-169.
33. Maras, M., Vanparys, C., Muylle, F., Robbens, J., Berger, U., Barber, J. L., Blust, R., and De Coen,W. (2006). Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation. Environ. Health Perspect. 114, 100-105.
34. Martin, J.W., Mabury, S. A., and O'Brien, P. J. (2005). Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes. Chem. Biol. Interact. 155, 165-180.
35. Martin, J. W., Muir, D. C., Moody, C. A., Ellis, D. A., Kwan, W. C., Solomon, K. R., and Mabury, S. A. (2002). Collection of airborne fluorinated organics and analysis by gas chromatography/chemical ionization mass spectrometry. Anal. Chem. 74, 584-590.
36. Milne, M. D., Scribner, B. H., and Crawford, M. A. (1958). Non-ionic diffusion and the excretion of weak acids and bases. Am. J. Med. 24, 709-729.
37. Mylchreest, E., Munley, S. M., and Kennedy, G. L., Jr. (2005). Evaluation of the developmental toxicity of 8-2 telomer B alcohol. Drug Chem. Toxicol. 28, 315-328.
38. Nau, H., and Scott, W. J., Jr. (1986). Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo. Nature 323, 276-278.
39. Ngan, F., and Toofan, M. (1991). Modification of preparation of diazomethane for methyl esterification of environmental samples analysis by gas chromatography. J. Chromatogr. Sci. 29, 8-10.
40. O'Flaherty, E. J., Scott, W., Schreiner, C., and Beliles, R. P. (1992). A physiologically based kinetic model of rat and mouse gestation: Disposition of a weak acid. Toxicol. Appl. Pharmacol. 112, 245-256.
41. Ohmori, K., Kudo, N., Katayama, K., and Kawashima, Y. (2003). Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184, 135-140.
42. Olsen, G. W., Burris, J. M., Burlew, M. M., and Mandel, J. H. (2000). Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem. Toxicol. 23, 603-620.
43. Olsen, G. W., Church, T. R., Hansen, K., Burris, J. M., Butenhoff, J., Mandel, J. H., and Zobel, L. R. (2004a). Quantitative evaluation of perfluorooctanesulfonate (PFOS) and other fluorochemicals in the serum of children. J. Child. Health 2, 53-76.
44. Olsen, G. W., Church, T. R., Larson, E. B., van Belle, G., Lundberg, J. K., Hansen, K. J., Burris, J. M., Mandel, J. H., and Zobel, L. R. (2004b). Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 54, 1599-1611.
45. Olsen, G. W., Hansen, K. J., Stevenson, L. A., Burris, J. M., and Mandel, J. H. (2003). Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. Environ. Sci. Technol. 37, 888-891.
46. Olsen, G. W., Huang, H. Y., Helzlsouer, K. J., Hansen, K. J., Butenhoff, J. L., and Mandel, J. H. (2005). Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ. Health Perspect. 113, 539-545.
47. Olson, C. T., and Andersen, M. E. (1983). The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol. Appl. Pharmacol. 70, 362-372.
48. Powley, C. R., George, S. W., Ryan, T. W., and Buck, R. C. (2005). Matrix effect-free analytical methods for determination of perfluorinated carboxylic acids in environmental matrixes. Anal. Chem. 77, 6353-6558.
49. Prevedouros, K., Cousins, I. T., Buck, R. C., and Korzeniowski, S. H. (2006). Sources, fate and transport of perfluorocarboxylates. Environ. Sci. Technol. 40, 32-44.
50. Smithwick, M., Norstrom, R. J., Mabury, S. A., Solomon, K., Evans, T. J., Stirling, I., Taylor, M. K., and Muir, D. C. (2006). Temporal trends of perfluoroalkyl contaminants in polar bears (Ursus maritimus) from two locations in the North American Arctic, 1972-2002. Environ. Sci. Technol. 40, 1139-1143.
51. Staples, R. E. (1985). Improper interpretation of data concerning teratogenicity: A case report. Prog. Clin. Biol. Res. 163C, 161-163.
52. Stock, N. L., Lau, F. K., Ellis, D. A., Martin, J. W., Muir, D. C., and Mabury, S. A. (2004). Polyfluorinated telomer alcohols and sulfonamides in the North American troposphere. Environ. Sci. Technol. 38, 991-996.
53. Taniyasu, S., Kannan, K., So, M. K., Gulkowska, A., Sinclair, E., Okazawa, T., and Yamashita, N. (2005). Analysis of fluorotelomer alcohols, fluorotelomer acids, and short- and long-chain perfluorinated acids in water and biota. J. Chromatogr. A 1093, 89-97.
54. Terry, K. K., Elswick, B. A., Welsch, F., and Conolly, R. B. (1995). Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse. Toxicol. Appl. Pharmacol. 132, 103-114.
55. Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhoff, J. L., Stevenson, L. A., and Lau, C. (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol. Sci. 74, 369-381.
56. Tomy, G. T., Budakowski, W., Halldorson, T., Helm, P. A., Stern, G. A., Friesen, K., Pepper, K., Tittlemier, S. A., and Fisk, A. T. (2004). Fluorinated organic compounds in an eastern Arctic marine food web. Environ. Sci. Technol. 38, 6475-6481.
57. Wallington, T. J., Hurley, M. D., Xia, J., Wuebbles, D. J., Sillman, S., Ito, A., Penner, J. E., Ellis, D. A., Martin, J., Mabury, S. A., et al. (2006). Formation of C7F15COOH (PFOA) and other perfluorocarboxylic acids during the atmospheric oxidation of 8:2 fluorotelomer alcohol. Environ. Sci. Technol. 40, 924-930.
58. Wang, N., Szostek, B., Folsom, P. W., Sulecki, L. M., Capka, V., Buck, R. C., Berti, W. R., and Gannon, J. T. (2005). Aerobic biotransformation of 14Clabeled 8-2 telomer B alcohol by activated sludge from a domestic sewage treatment plant. Environ. Sci. Technol. 39, 531-538.
59. Yang, Q., Xie, Y., Alexson, S. E. H., Nelson, B. D., and DePierre, J. W. (2002). Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem. Pharmacol. 63, 1893-1900.